Huixian Zhang

Νo.1 Jianshe East Road
Zhengzhou, 450052, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Novel Zinc(II) 2,6-dimethoxybenzamidine Schiff Base Complexes: Design, Synthesis, X-ray Crystal Structure, Fluorescence Properties and Density Functional Theory Calculations.

Novel Zinc(II) 2,6-dimethoxybenzamidine Schiff Base Complexes: Design, Synthesis, X-ray Crystal Structure, Fluorescence Properties and Density Functional Theory Calculations.

Journal: Journal of fluorescence

Published: May 10, 2025

Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.

Corrigendum: The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.

Journal: Frontiers in oncology

Published: April 05, 2024

Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib.

Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib.

Journal: Frontiers in oncology

Published: March 23, 2024

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data.

Efficacy of chemo-immunotherapy in metastatic BRAF-mutated lung cancer: a single-center retrospective data.

Journal: Frontiers in oncology

Published: December 10, 2023

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.

Response to immune checkpoint inhibitor combination therapy in metastatic RET-mutated lung cancer from real-world retrospective data.

Journal: BMC cancer

Published: November 07, 2023

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment.

Case report: The effect of second-line vebreltinib treatment on a patient with advanced NSCLC harboring the MET exon 14 skipping mutation after tepotinib treatment.

Journal: Frontiers in oncology

Published: November 01, 2023

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.

The efficacy of furmonertinib in untreated advanced NSCLC patients with sensitive EGFR mutations in a real-world setting: a single institutional experience.

Journal: Frontiers in oncology

Published: October 31, 2023

Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients.

Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients.

Journal: Medicine

Published: July 21, 2023

Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report.

Corrigendum: Case Report: Durable response to immuno-chemotherapy in a case of ROS1 fusion-positive advanced lung adenocarcinoma: A case report.

Journal: Frontiers in pharmacology

Published: July 20, 2023

Retraction Note: LINC01089 functions as a ceRNA for miR-152-3p to inhibit non-small lung cancer progression through regulating PTEN.

Retraction Note: LINC01089 functions as a ceRNA for miR-152-3p to inhibit non-small lung cancer progression through regulating PTEN.

Journal: Cancer cell international

Published: December 08, 2022

Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma.

Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma.

Journal: Clinical epigenetics

Published: December 07, 2022

Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253.

Macrophage-derived exosomes regulate gastric cancer cell oxaliplatin resistance by wrapping circ 0008253.

Journal: Cell cycle (Georgetown, Tex.)

Published: November 23, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026